1 |
American Joint Committee on Cancer. AJCC Cancer Staging Hand book. 6th ed. Philadelphia: Lippincott-Raven, 2002.
|
2 |
Brenner B, Ilson DH, Minsky BD (2004). Treatment of localized esophageal cancer. Semin Oncol, 31, 554-65.
DOI
|
3 |
Chinese Society of Esophagenal Cancer, Chinese Anti-Cancer Association (2011). Clinical Practice Guidelines for the Diagnosis and Treatment of Esophageal Cancer [M] Beijing: China Union Medical University Press, 116-9.
|
4 |
Li X, Zhou F, Ren Z, et al (2007). Phase Ⅱ trail of Lobaplatin, leucovorin and fluorouracil in patient s with advanced carcinoma of the esophagus. Chin J Cancer Prev Treat, 14, 65-7.
|
5 |
Lin Y, Chen J, Li J, et al (2012). Recent results of concurrent chemoradiotherapy with lobaplatin and paclitaxel in advanced esophageal carcinoma. Cancer Res Clinic, 24, 105-7.
|
6 |
Mckeage MJ (2001). Lobaplatin: a new antitumour platinum drug. Expert Opin Investig Drugs, 10, 119-28.
DOI
ScienceOn
|
7 |
Mei, J, Liu J, Yao W (2002). Concurrent chemoradiotherapy for locoregional esophageal cancer. Chin J Clin Oncol Rehab, 9, 98-9.
|
8 |
Polee MB, Tilanus HW, Eskens FA (2003). Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. Ann Oncol, 14, 1253-7.
DOI
|
9 |
Schmoll HJ, Kohne CH, Papagerorion E, et al (1995). Single angent lobaplatin is active in patients with esophageal squamous cell carcinoma: a phase II evaluation. Proc Am Soc Clin Oncol, 14, 483.
|
10 |
Sun Y, Zhou J (2003). Manual of Medical Oncology [M] 4th edition. Beijing: People's Medical Publishing House, 2003: 106-107, 274-276.
|
11 |
Urba SG, Orringer MB, Ianettonni M, et al (2003). Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma. Cancer, 98, 2177-83.
DOI
|
12 |
Ye H (2002). Combined chemoradiotherapy in the in the treatment of middle-advanced stage esophageal cancers. Cancer Res Clinic, 14, 187-8.
|
13 |
Zhao KI, Shi XH, Jiang GL, et al (2005). Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. Int J Radiat Oncol Biol Phys, 62, 1014-20.
DOI
|